Editorial: Natural products in the fight against antibiotic resistance: addressing the WHO priority pathogens
Antimicrobial resistance (AMR) continues to escalate as a global health crisis, driven by the rapid emergence of multidrug-resistant (MDR) pathogens and the diminishing efficacy of existing antibiotics. The World Health Organization (WHO) priority pathogen list has provided a critical framework to guide research and therapeutic development; however, progress in addressing these pathogens remains uneven. This research topic brings together studies examining the scientific and translational landscape of antimicrobial discovery, with particular emphasis on natural products and related strategies targeting WHO-priority bacteria, as summarized in Figure 1.
Authors
- Tushar Dhanani (ORCID: https://orcid.org/0000-0001-8200-7297)
- John T. Arnason (ORCID: https://orcid.org/0000-0001-5354-5715)
- Maryam Shafaati (ORCID: https://orcid.org/0000-0002-7401-2237)
- Sushmita Nath (ORCID: https://orcid.org/0000-0001-9858-0696)
Institutions
- University of Ottawa (CA)
- Imam Khomeini Hospital (IR)
- University Hospital Münster (DE)
- Ministry of Health and Medical Education (IR)
- Center for Non-Communicable Diseases (PK)
- Florida Agricultural and Mechanical University (US)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-04-27
- DOI
- https://doi.org/10.3389/fphar.2026.1845222
- Primary Topic
- Microbial Natural Products and Biosynthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00